Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ecs Botanics Holdings Ltd ( (AU:ECS) ) has provided an announcement.
ECS Botanics Holdings Ltd has announced a significant milestone in its business operations, with B2C sales surpassing 60% of total revenue for the first time in October 2025. This growth is driven by the launch of new sugar-free, vegan THC gummies under the OzSun brand, now available nationwide, and a strategic partnership with Burleigh Heads Cannabis, facilitating the listing of ECS products on the Canview platform. These developments are expected to enhance ECS’s market presence, particularly in the crowded gummies category, and expand patient access to its products, further supporting the company’s growth strategy and positioning it for increased market share.
More about Ecs Botanics Holdings Ltd
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer based in Northwest Victoria. The company employs innovative cultivation methods to produce high-quality, affordable medicinal cannabis using regenerative and organic horticultural practices and renewable energy. ECS is licensed by the Australian Therapeutic Goods Administration to manufacture GMP-certified products, establishing itself as a leading provider in the industry.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.78M
For a thorough assessment of ECS stock, go to TipRanks’ Stock Analysis page.

